Pennsylvania medical cannabis patients reported improved quality of life within 30 days

Among 103 Pennsylvania medical cannabis patients followed for 90 days, significant improvements in physical functioning, emotional well-being, and pain were observed within the first month and sustained throughout the study.

Kelley, Mark D et al.·Medical cannabis and cannabinoids·2024·Preliminary EvidenceObservational
RTHC-05420ObservationalPreliminary Evidence2024RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Observational
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Participants showed significant improvements in physical and social functioning, emotional well-being, and energy within 30 days that persisted through 90 days. Those using inhaled or vaped products showed greater emotional well-being improvement than flower users. Patients using cannabis for opioid use consumed significantly more THC than those treating anxiety, chronic pain, or IBD.

Key Numbers

103 completers over 90 days; significant improvements in physical functioning, social functioning, emotional well-being, and energy within first 30 days; significant decreases in emotional limitations, fatigue, and pain; vapers showed higher emotional well-being gains than flower users

How They Did This

Prospective observational study of 103 Pennsylvania Medical Marijuana Program patients surveyed electronically every 30 days over 90 days about use patterns and quality of life changes.

Why This Research Matters

Real-world data from state medical cannabis programs can help bridge the evidence gap between clinical trials and how patients actually experience medical cannabis in practice.

The Bigger Picture

As more states implement medical cannabis programs, understanding patient-reported outcomes across different conditions and consumption methods helps inform both clinical practice and policy.

What This Study Doesn't Tell Us

No control group; self-selected patients likely positive toward cannabis; short 90-day follow-up; self-reported outcomes without clinical verification; no blinding; potential placebo effect

Questions This Raises

  • ?Do these quality of life improvements persist beyond 90 days?
  • ?Why did vape/inhaled users show greater emotional well-being improvement than flower users?
  • ?What accounts for the higher THC consumption among those treating opioid use?

Trust & Context

Key Stat:
103 patients showed improvements within 30 days
Evidence Grade:
Uncontrolled prospective survey of self-selected medical cannabis patients without blinding or clinical verification of outcomes.
Study Age:
2024 study with 90-day follow-up
Original Title:
Observational Analysis of the Influence of Medical Marijuana Use on Quality of Life in Patients.
Published In:
Medical cannabis and cannabinoids, 7(1), 44-50 (2024)
Database ID:
RTHC-05420

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Watches what happens naturally without intervening.

What do these levels mean? →

Frequently Asked Questions

How quickly did patients see benefits from medical cannabis?

Significant improvements in physical and social functioning, emotional well-being, energy, and pain were observed within the first 30 days of the study. These improvements held steady through the full 90-day follow-up period.

Did the method of consumption matter?

Participants who used inhaled or vaped products (cartridges and concentrates) showed significantly greater improvements in emotional well-being compared to those who used flower. Vape users also tended to be younger.

Read More on RethinkTHC

Cite This Study

RTHC-05420·https://rethinkthc.com/research/RTHC-05420

APA

Kelley, Mark D; Obaid, Marwah; Miller, Edward M; Bowie, Marla; Heeter, Zachary S. (2024). Observational Analysis of the Influence of Medical Marijuana Use on Quality of Life in Patients.. Medical cannabis and cannabinoids, 7(1), 44-50. https://doi.org/10.1159/000536591

MLA

Kelley, Mark D, et al. "Observational Analysis of the Influence of Medical Marijuana Use on Quality of Life in Patients.." Medical cannabis and cannabinoids, 2024. https://doi.org/10.1159/000536591

RethinkTHC

RethinkTHC Research Database. "Observational Analysis of the Influence of Medical Marijuana..." RTHC-05420. Retrieved from https://rethinkthc.com/research/kelley-2024-observational-analysis-of-the

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.